
THE EFFECTIVENESS OF OCTREOTIDE IN THE TREATMENT OF ACROMEGALY.
Kodirov Avaz Eshmamatovich , Scientific supervisor: PhD. Abduvoxidova Aziza Akmalovna , Samarkand State Medical University, Uzbekistan Maxmiev Daler Nizomjon ugli , Samarkand State Medical University, Uzbekistan Jaxongirov Xondamir Najmiddin ugli , Samarkand State Medical University, Uzbekistan Maxmaraemov Islom Xamza ugli , Samarkand State Medical University, UzbekistanAbstract
Acromegaly is from Greek. acron is a limb, megalos is a large one associated with impaired function of the anterior pituitary gland. The cause of acromegaly in 95% of cases is excessive secretion of STH (somatotropic hormone) by pituitary adenoma, which is not associated with genetic diseases of the endocrine system. Hypersecretion of STH occurs due to gene mutations at the level of α-subunits of the G protein, under the influence of which tumor cell proliferation and increased secretory activity occur.In the remaining 5% of cases, acromegaly is one of the manifestations of hereditary genetically mediated diseases.
Keywords
acromegaly, clinical picture, X-ray of the skull, octreotide treatment, reduction of adenoma size, additional therapy.
References
AACE Medical Guidelines for Clinical Practice for the diagnosis and treatment of acromegaly. Endor Pract. 2004, 10:213-225.
Adam N. Lim SS, Ananda V, Chan SP. VIPoma syndrome: chalenges in management. Singapore Med J. 2010 Jut51(7pe 129-32.
Alexa Appleton D, Hall R, Ross WM, Willinson R. Epidemiology of acromegaly in the Newcastle region. Clin Endoninol (Oxf). 1960 Jan; 12(1):71 -9.
American Gastroenderological Association. American Gastroenterological Association medical position statement: Short bowel syndrome and intestinal transplantation Gastroenterology.2008,1244):1105-1110.
Barkun. A, Bardou M, Marshal JK, et al. Consensus recommendations for managing patients with novariceal upper gastrointestinal bleeding. Ann Intern Med. 2003;139 10:843 -857.
Bengtsson BA, Eden S, Ernest 1, Oden A. Sjogren B. Epidemiology and long-term survival in acromegaly. A study af 166 cases diagnosed between 1955 and 1984. Acta Med Scand. 1988,223/4) 327-35.
Bissonnerte RT, Gibney RG, Berry BR, Bucidey AR. Fatal carcincid crisis after percu-taneous fine-needle biopsy of heparic metastasis: case report and Inerature review. Radiology. 1990 Mar, 174(3 Pt 11:751-2.
Brazeau P. Vale WI, Burgus R, Ling N, Butcher M. Rivier J, Guilemin R. Hypothelaric polpectde that inficis the secretion of immunoreactive pituttary growth hormone Science. 1973 Jan 5;179(68):77-9.
Carley DA, Celo JP, Adkisson VI, et al. Octreotide for acute esophageal variceal bleed. ing: A meta-analysis. Gastroenterology. 2001;12014)-946-954.
Cozzi R, Atanasio R, Moribini M, Pagani G, Lasio G, Lodini S, Barausse M, Ribizi M, Dallabonzara D, Pedroncels All. Four-year treatmant with octreatide-long-acting re-pestable in 110 acromegalic patients: predictive value of short-term results? J Clin Endocrinal Metab. 2008 Jut88(7) 3090-8.
Dalm VA, Hofiand W. Lamberts SW. Future clinical prospects in somatostarin/cortistatin/ somatostatin receptor field. Mol Cel Endoorinal. 2008 May 14;286(1-2):262-77.
Article Statistics
Downloads
Copyright License

This work is licensed under a Creative Commons Attribution 4.0 International License.